STEMI — Reperfusion First

Key Points

• Do not wait for troponin before activating reperfusion for a diagnostic STEMI presentation.
• Primary PCI is the preferred reperfusion method when it can be delivered promptly.
• Fibrinolysis is an alternative for selected early presenters when timely PCI is unavailable and contraindications are absent.
• Give aspirin immediately unless contraindicated and use guideline-directed P2Y12 and anticoagulant therapy.
• Routine oxygen is unnecessary when oxygen saturation is adequate.
• Consider aortic dissection before antithrombotics when symptoms or examination make it plausible.
• Shock, new murmur, or sudden pulmonary edema should trigger concern for mechanical complications.
• Secondary prevention and cardiac rehabilitation begin during the index hospitalization.

Algorithm

1. Obtain and interpret a 12-lead ECG immediately; obtain posterior or right-sided leads when indicated.
2. Activate the PCI/reperfusion system as soon as STEMI is identified.
3. Give aspirin and initiate the antithrombotic regimen appropriate to PCI or fibrinolysis.
4. Assess for shock, heart failure, arrhythmia, aortic dissection, and major bleeding contraindications.
5. Proceed to primary PCI when timely access is available; use fibrinolysis for selected early patients when it is not.
6. Transfer fibrinolysis-treated patients to a PCI-capable center and perform rescue PCI when reperfusion fails.
7. Monitor for recurrent ischemia, arrhythmia, and mechanical complications and obtain echocardiography during hospitalization.
8. Start secondary prevention and arrange cardiac rehabilitation before discharge.

Clinical Synopsis & Reasoning

STEMI is usually caused by abrupt thrombotic occlusion of an epicardial coronary artery after plaque disruption. Symptoms may include pressure-like chest discomfort, dyspnea, diaphoresis, nausea, epigastric discomfort, syncope, or unexplained weakness. Older adults, patients with diabetes, and women can present atypically. Obtain a 12-lead ECG within minutes of arrival and repeat it when the first tracing is nondiagnostic but ischemic symptoms continue. Posterior and right-sided leads improve recognition of posterior or right-ventricular infarction when suspected.

Diagnosis is driven by the ECG and clinical syndrome, not by waiting for troponin. New ST elevation in contiguous leads, appropriate STEMI-equivalent patterns, or ongoing ischemia with diagnostic posterior findings requires immediate reperfusion decision-making. Mimics include pericarditis, early repolarization, left ventricular hypertrophy, hyperkalemia, ventricular aneurysm, Takotsubo syndrome, myocarditis, and pulmonary embolism. When aortic dissection is plausible, antithrombotic and fibrinolytic treatment can be catastrophic and should be withheld until dissection is reasonably excluded.

Risk assessment includes cardiogenic shock, acute heart failure, malignant arrhythmia, mechanical complications, right-ventricular involvement, and bleeding risk. Point-of-care echocardiography can clarify shock or a mechanical complication but should not postpone the catheterization laboratory in an otherwise clear STEMI. Check radial and femoral pulses, blood pressure in unstable patients, lungs, murmurs, and signs of congestion. A new harsh systolic murmur, sudden pulmonary edema, or abrupt shock can indicate papillary-muscle rupture, ventricular septal rupture, or free-wall rupture and demands emergent imaging and surgical involvement.

Treatment Strategy & Disposition

Activate primary PCI immediately. The 2025 ACC/AHA ACS guideline continues to prioritize an invasive reperfusion strategy for STEMI when timely PCI is available. Aspirin should be chewed promptly unless there is a true contraindication. Add a P2Y12 inhibitor according to the planned reperfusion strategy, bleeding risk, prior anticoagulation, and potential need for urgent surgery. Anticoagulation is given according to PCI or fibrinolytic pathway. Radial arterial access is generally preferred for PCI when feasible because it reduces bleeding and vascular complications.

If the patient presents early and timely PCI cannot be delivered, fibrinolysis can be considered when there are no contraindications, followed by transfer to a PCI-capable center. Failure of fibrinolysis or recurrent ischemia requires rescue PCI. Oxygen is given for hypoxemia rather than routinely to every normoxic patient. Nitroglycerin can relieve ischemic pain and reduce preload but should be avoided with hypotension, suspected right-ventricular infarction with preload dependence, recent phosphodiesterase-5 inhibitor use, or other contraindications. Opioids are reserved for severe refractory pain because they can delay absorption of oral antiplatelet therapy.

Treat cardiogenic shock with urgent revascularization and hemodynamic support while avoiding routine multivessel PCI of nonculprit lesions during the initial shock procedure unless a specific circumstance justifies it. Begin high-intensity statin therapy, and introduce evidence-based beta blocker, ACE inhibitor/ARB/ARNI, mineralocorticoid antagonist, and other secondary-prevention therapy when hemodynamically appropriate. Monitor for arrhythmia, heart failure, recurrent ischemia, pericarditis, and mechanical complications. Cardiac rehabilitation and smoking cessation are part of definitive treatment.

Epidemiology / Risk Factors

• Acute coronary syndromes remain a leading cause of cardiovascular morbidity and mortality worldwide.
• Smoking, diabetes, hypertension, dyslipidemia, chronic kidney disease, and established atherosclerosis increase risk.
• Modern regional STEMI systems have improved survival by shortening time to reperfusion.
• Cardiogenic shock occurs in a minority of cases but accounts for disproportionate early mortality.
• Recurrent cardiovascular risk remains substantial after hospital discharge without intensive secondary prevention.

Investigations

Reperfusion Options

Pharmacology

Prognosis / Complications

• Rapid successful reperfusion substantially improves survival and preserves ventricular function.
• Cardiogenic shock, cardiac arrest, large anterior infarction, delayed presentation, and mechanical complications worsen prognosis.
• Reduced ejection fraction increases later heart-failure and arrhythmia risk.
• Bleeding complications can adversely affect outcome and are reduced by careful antithrombotic selection and radial access when feasible.
• Adherence to secondary prevention and cardiac rehabilitation improves long-term functional and cardiovascular outcomes.

Patient Education / Counseling

• Call emergency services for recurrent chest pressure, severe dyspnea, syncope, or symptoms similar to the original infarction.
• Take dual antiplatelet therapy exactly as prescribed and never stop it without discussing the reason with the cardiology team.
• Participate in cardiac rehabilitation and gradually resume activity according to the rehabilitation plan.
• Stop smoking and address blood pressure, diabetes, lipids, sleep, diet, and weight as part of recurrent-event prevention.
• Keep nitroglycerin instructions clear if it is prescribed, including when to call emergency services.
• Attend cardiology follow-up for ventricular function, symptoms, medication titration, and return-to-work or activity guidance.

Notes

The 2025 ACC/AHA acute coronary syndrome guideline consolidates STEMI and NSTE-ACS management and emphasizes rapid reperfusion, contemporary antiplatelet therapy, bleeding reduction, and complete secondary prevention.

Time is myocardium, but speed must still be paired with diagnostic discipline. Aortic dissection and other catastrophic mimics can be harmed by reflex fibrinolysis or antithrombotic therapy.

References

1. 2025 ACC AHA Acute Coronary Syndromes Guideline — Link
2. American Heart Association Acute Coronary Syndrome Resources — Link